Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lymphoma 2Sclerosteosis 1Periodontitis 1Periodontal Diseases 1Osteoporosis, Postmenopausal 1Neoplasms 1Motor Activity 1Lymphoma, Large B-Cell, Diffuse 1Liver Cirrhosis 1Leukemia, Promyelocytic, Acute 1Gastrointestinal Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Weights and Measures × Clear all
NCT03262831 2019-09-03

Mindful Movement in Women Receiving Adjuvant or Neoadjuvant Therapy for Breast Cancer

Washington University School of Medicine

Phase NA Completed
30 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡